1. Home
  2. VALU vs ARMP Comparison

VALU vs ARMP Comparison

Compare VALU & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Value Line Inc.

VALU

Value Line Inc.

HOLD

Current Price

$35.92

Market Cap

353.1M

Sector

Finance

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$9.35

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALU
ARMP
Founded
1931
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.1M
383.7M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
VALU
ARMP
Price
$35.92
$9.35
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
959.0
29.4K
Earning Date
03-16-2026
03-25-2026
Dividend Yield
3.61%
N/A
EPS Growth
8.91
N/A
EPS
1.92
N/A
Revenue
$36,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.74
N/A
Revenue Growth
1.08
N/A
52 Week Low
$35.15
$0.90
52 Week High
$41.85
$13.75

Technical Indicators

Market Signals
Indicator
VALU
ARMP
Relative Strength Index (RSI) 44.39 50.66
Support Level $35.15 $5.14
Resistance Level $38.09 $12.11
Average True Range (ATR) 0.47 0.99
MACD -0.02 -0.29
Stochastic Oscillator 37.22 43.11

Price Performance

Historical Comparison
VALU
ARMP

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: